ID   Pell-1
AC   CVCL_B7AR
DR   Wikidata; Q112129502
RX   PubMed=34821060;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=34821060).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=34821060
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 12,16
ST   D21S11: 32.2,33
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
RX   PubMed=34821060; DOI=10.1002/cam4.4394; PMCID=PMC8683535;
RA   Nishimori, Tomohiro
RA   Higuchi, Tomonori
RA   Hashida, Yumiko
RA   Ujihara, Takako
RA   Taniguchi, Ayuko
RA   Ogasawara, Fumiya
RA   Kitamura, Naoya
RA   Murakami, Ichiro
RA   Kojima, Kensuke
RA   Daibata, Masanori
RT   "Development of a novel cell line-derived xenograft model of primary
RT   herpesvirus 8-unrelated effusion large B-cell lymphoma and antitumor
RT   activity of birabresib in vitro and in vivo.";
RL   Cancer Med. 10:8976-8987(2021).
//